Lindora
Effectively Tackling America's Obesity Problem
Overview
Raised: $0
Rolling Commitments ($USD)
04/19/2022
$0
2022
Healthcare & Pharmaceuticals
HealthTech
B2C
Low
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$35,478,000 |
$35,654,000 |
COGS |
$22,750,000 |
$22,750,000 |
Tax |
$-68,000 |
$96,000 |
| ||
| ||
Net Income |
$-1,162,000 |
$-1,751,000 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$3,780,000 |
$1,117,000 |
Accounts Receivable |
$251,000 |
$405,000 |
Total Assets |
$9,210,000 |
$6,434,000 |
Short-Term Debt |
$9,576,000 |
$3,720,000 |
Long-Term Debt |
$2,530,000 |
$4,891,000 |
Total Liabilities |
$12,106,000 |
$8,611,000 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual